INFI Historical PE Ratio image   This INFI PE ratio history page last updated 11/15/2022
INFI Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/14/2022
0.74-0.12-0.48NA
Q2 2022
8/9/2022
0.74-0.13-0.52NA
Q1 2022
5/3/2022
0.84-0.14-0.56NA
Q4 2021
3/29/2022
1.00-0.13-0.52NA
Q3 2021
11/2/2021
2.63-0.12-0.48NA
Q2 2021
7/27/2021
1.52-0.13-0.52NA
Q1 2021
5/13/2021
2.66-0.15-0.60NA
Q4 2020
3/16/2021
3.10-0.17-0.68NA
Q3 2020
11/9/2020
1.15-0.16-0.64NA
Q2 2020
7/30/2020
0.83-0.16-0.64NA
Q1 2020
5/11/2020
1.01-0.19-0.76NA
Q4 2019
3/3/2020
1.10-0.20-0.80NA
Q3 2019
10/30/2019
1.02-0.20-0.80NA
Q2 2019
7/30/2019
1.57-0.18-0.72NA
Q1 2019
5/7/2019
1.70-0.24-0.96NA
Q4 2018
3/14/2019
1.91-0.14-0.56NA
Q3 2018
11/5/2018
2.380.230.922.6
Q2 2018
8/7/2018
1.87-0.12-0.48NA
Q1 2018
5/8/2018
2.08-0.18-0.72NA
Q4 2017
3/15/2018
2.74-0.14-0.56NA
Q3 2017
11/7/2017
2.44-0.14-0.56NA
Q2 2017
8/3/2017
1.36-0.34-1.36NA
Q1 2017
5/9/2017
1.84-0.21-0.84NA
Q4 2016
3/14/2017
2.95-0.46-1.84NA
Q3 2016
11/9/2016
1.17-0.39-1.56NA
Q2 2016
8/9/2016
1.61-1.20-4.80NA
Q1 2016
5/4/2016
5.44-0.82-3.28NA
Q4 2015
2/23/2016
5.63-0.80-3.20NA
Q3 2015
11/5/2015
10.510.843.363.1
Q2 2015
8/6/2015
8.25-0.78-3.12NA
Q1 2015
5/6/2015
12.16-1.91-7.64NA
Q4 2014
2/24/2015
15.13-0.83-3.32NA
Q3 2014
11/6/2014
12.142.038.121.5
Q2 2014
8/5/2014
9.98-0.78-3.12NA
Q1 2014
5/6/2014
9.05-0.87-3.48NA
Q4 2013
2/25/2014
16.15-0.68-2.72NA
Q3 2013
11/7/2013
11.97-0.71-2.84NA
Q2 2013
8/8/2013
20.00-0.68-2.72NA
Q1 2013
5/7/2013
34.81-0.57-2.28NA
Q4 2012
3/5/2013
45.14-1.48-5.92NA
Q3 2012
11/6/2012
20.200.522.089.7
Q2 2012
8/7/2012
15.36-0.54-2.16NA
Q1 2012
5/8/2012
13.31-0.40-1.60NA
INFI PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/14/2022
0.74-0.12-0.52NA
Q2 2022
8/9/2022
0.74-0.13-0.52NA
Q1 2022
5/3/2022
0.84-0.14-0.52NA
Q4 2021
3/29/2022
1.00-0.13-0.53NA
Q3 2021
11/2/2021
2.63-0.12-0.57NA
Q2 2021
7/27/2021
1.52-0.13-0.61NA
Q1 2021
5/13/2021
2.66-0.15-0.64NA
Q4 2020
3/16/2021
3.10-0.17-0.68NA
Q3 2020
11/9/2020
1.15-0.16-0.71NA
Q2 2020
7/30/2020
0.83-0.16-0.75NA
Q1 2020
5/11/2020
1.01-0.19-0.77NA
Q4 2019
3/3/2020
1.10-0.20-0.82NA
Q3 2019
10/30/2019
1.02-0.20-0.76NA
Q2 2019
7/30/2019
1.57-0.18-0.33NA
Q1 2019
5/7/2019
1.70-0.24-0.27NA
Q4 2018
3/14/2019
1.91-0.14-0.21NA
Q3 2018
11/5/2018
2.380.23-0.21NA
Q2 2018
8/7/2018
1.87-0.12-0.58NA
Q1 2018
5/8/2018
2.08-0.18-0.80NA
Q4 2017
3/15/2018
2.74-0.14-0.83NA
Q3 2017
11/7/2017
2.44-0.14-1.15NA
Q2 2017
8/3/2017
1.36-0.34-1.40NA
Q1 2017
5/9/2017
1.84-0.21-2.26NA
Q4 2016
3/14/2017
2.95-0.46-2.87NA
Q3 2016
11/9/2016
1.17-0.39-3.21NA
Q2 2016
8/9/2016
1.61-1.20-1.98NA
Q1 2016
5/4/2016
5.44-0.82-1.56NA
Q4 2015
2/23/2016
5.63-0.80-2.65NA
Q3 2015
11/5/2015
10.510.84-2.68NA
Q2 2015
8/6/2015
8.25-0.78-1.49NA
Q1 2015
5/6/2015
12.16-1.91-1.49NA
Q4 2014
2/24/2015
15.13-0.83-0.45NA
Q3 2014
11/6/2014
12.142.03-0.30NA
Q2 2014
8/5/2014
9.98-0.78-3.04NA
Q1 2014
5/6/2014
9.05-0.87-2.94NA
Q4 2013
2/25/2014
16.15-0.68-2.64NA
Q3 2013
11/7/2013
11.97-0.71-3.44NA
Q2 2013
8/8/2013
20.00-0.68-2.21NA
Q1 2013
5/7/2013
34.81-0.57-2.07NA
Q4 2012
3/5/2013
45.14-1.48-1.90NA
Q3 2012
11/6/2012
20.200.52NANA
Q2 2012
8/7/2012
15.36-0.54NANA
Q1 2012
5/8/2012
13.31-0.40NANA
Quotes delayed 20 minutes

Email EnvelopeFree INFI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Infinity Pharmaceuticals (INFI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

INGN PE Ratio History
INMB PE Ratio History
INNV PE Ratio History
INO PE Ratio History
INSM PE Ratio History
INSP PE Ratio History
INVA PE Ratio History
INVO PE Ratio History
INZY PE Ratio History
IONS PE Ratio History
How should the INFI historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Infinity Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this INFI Historical PE Ratio page.

What is the average historical PE for INFI based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The INFI historical PE ratio using the annualized quarterly earnings method works out to 4.2.

What is the average historical PE for INFI based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The INFI historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the INFI Historical PE Ratio information for Infinity Pharmaceuticals' stock. The average INFI historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 4.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average INFI historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this INFI historical PE result, against the recent PE: when this page was posted on 11/14/2022, the most recent closing price for INFI had been 0.74, and the most recent quarterly earnings result, annualized, was 0.92. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent INFI PE on 11/14/2022 based on annualized quarterly EPS was 0.8. Based on INFI's history, that recent PE is low relative to the historical average, with the recent PE 81.0% lower than the historical average PE across our data set for Infinity Pharmaceuticals.

For self directed investors doing their due diligence on INFI or any other given stock, valuation analysis for INFI can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Infinity Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for INFI. Thanks for visiting, and the next time you need to research INFI Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: LODE Insider Buying, Fiserv Technical Analysis, Top Ten Hedge Funds Holding KRTX.

 

INFI Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.